scPharmaceuticals Inc
SCPH5.620USD
-0.010-0.18%
收盘 09/18, 16:00（美东）报价延迟15分钟
299.49M总市值
亏损市盈率 TTM
关于 scPharmaceuticals Inc 公司
scPharmaceuticals Inc. 是一家制药公司。该公司专注于开发和商业化产品，以优化输注疗法的输送、提高患者护理水平并降低医疗成本。该公司通过内部和战略合作伙伴关系开发产品和解决方案，旨在扩大和提高特定急性疾病的门诊护理。其主要候选产品 FUROSCIX 包括通过随身输注器输送的呋塞米配方。FUROSCIX 是一种呋塞米配方，包含在预填充的 Crystal Zenith 药筒中，通过一次性、可抛弃和可穿戴的随身输送系统进行皮下自我给药。该公司的管道项目包括 SCP-111（呋塞米注射液）80mg/mL，这是一种研究性 pH 中性水性呋塞米配方，正在开发用于医院环境外的皮下给药，包括患者在家中自我给药。
公司简介
公司代码SCPH
公司名称scPharmaceuticals Inc
上市日期Nov 17, 2017
CEOMr. John H. Tucker
员工数量162
证券类型Ordinary Share
年结日Nov 17
公司地址25 Burlington Mall Road, Suite 203
城市BURLINGTON
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编01803
电话16175170730
网址https://www.scpharmaceuticals.com/
公司代码SCPH
上市日期Nov 17, 2017
CEOMr. John H. Tucker
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. John H. Tucker
Mr. John H. Tucker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
122.34K
-55.88%
Mr. Leonard D. Schaeffer
Mr. Leonard D. Schaeffer
Independent Director
Independent Director
111.90K
--
Ms. Rachael Nokes
Ms. Rachael Nokes
Chief Financial Officer
Chief Financial Officer
30.39K
-71.18%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Mette Kirstine Agger
Ms. Mette Kirstine Agger
Independent Director
Independent Director
--
--
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Independent Director
Independent Director
--
--
Ms. Katherine Miranda
Ms. Katherine Miranda
Senior Manager - Corporate Communication
Senior Manager - Corporate Communication
--
--
Mr. Jack A. Khattar
Mr. Jack A. Khattar
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Dr. Klaus Veitinger, M.D., Ph.D.
Dr. Klaus Veitinger, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. William T. Abraham, M.D.
Dr. William T. Abraham, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John H. Tucker
Mr. John H. Tucker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
122.34K
-55.88%
Mr. Leonard D. Schaeffer
Mr. Leonard D. Schaeffer
Independent Director
Independent Director
111.90K
--
Ms. Rachael Nokes
Ms. Rachael Nokes
Chief Financial Officer
Chief Financial Officer
30.39K
-71.18%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Mette Kirstine Agger
Ms. Mette Kirstine Agger
Independent Director
Independent Director
--
--
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月13日 周六
更新时间: 9月13日 周六
持股股东
股东类型
持股股东
持股股东
占比
OrbiMed Advisors, LLC
11.29%
Rubric Capital Management LP
8.57%
Luther King Capital Management Corp.
6.60%
Lytton (Laurence W)
5.49%
AIGH Capital Management, LLC.
5.40%
其他
62.65%
持股股东
持股股东
占比
OrbiMed Advisors, LLC
11.29%
Rubric Capital Management LP
8.57%
Luther King Capital Management Corp.
6.60%
Lytton (Laurence W)
5.49%
AIGH Capital Management, LLC.
5.40%
其他
62.65%
股东类型
持股股东
占比
Investment Advisor
26.25%
Hedge Fund
19.70%
Private Equity
17.73%
Investment Advisor/Hedge Fund
10.47%
Individual Investor
5.98%
Research Firm
3.74%
Venture Capital
2.30%
Bank and Trust
0.14%
Insurance Company
0.02%
其他
13.67%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
207
43.86M
83.06%
-9.87M
2025Q1
220
46.17M
87.73%
-9.39M
2024Q4
216
48.09M
96.18%
-7.84M
2024Q3
205
45.54M
91.15%
-1.25M
2024Q2
187
32.09M
87.10%
-11.64M
2024Q1
180
29.20M
80.96%
-13.79M
2023Q4
174
29.67M
82.49%
-9.34M
2023Q3
165
32.24M
89.90%
-5.09M
2023Q2
160
30.81M
85.97%
-2.10M
2023Q1
135
26.76M
76.80%
-865.96K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
OrbiMed Advisors, LLC
6.06M
11.48%
--
--
Mar 31, 2025
Rubric Capital Management LP
4.78M
9.04%
--
--
Mar 31, 2025
Luther King Capital Management Corp.
3.12M
5.91%
+263.26K
+9.21%
Mar 31, 2025
Lytton (Laurence W)
2.94M
5.58%
+1.12M
+61.35%
Sep 30, 2024
AIGH Capital Management, LLC.
3.10M
5.86%
--
--
Mar 31, 2025
Lundbeckfond Invest
2.86M
5.42%
+2.86M
--
Sep 30, 2024
BlackRock Institutional Trust Company, N.A.
2.15M
4.08%
+43.64K
+2.07%
Mar 31, 2025
The Vanguard Group, Inc.
1.99M
3.77%
-115.70K
-5.49%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.65M
3.12%
-29.52K
-1.76%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.64%
iShares Micro-Cap ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.03%
Invesco Nasdaq Biotechnology ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.64%
iShares Micro-Cap ETF
占比0.04%
ProShares Ultra Nasdaq Biotechnology
占比0.03%
Invesco Nasdaq Biotechnology ETF
占比0.03%
Global X Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
